Drug discovery research collaboration is announced

Article

Leica Microsystems and Definiens have announced a co-marketing agreement.

Leica Microsystems and Definiens have announced a co-marketing agreement.

Global precision optical system designer and producer Leica Microsystems will market their products with biomedical image analysis developer Definiens. Both firms will host educational events and workshops. Definiens Developer XD will analyze data created by Leica's confocal microscopes.

Thomas P. Heydler, CEO of Definiens, said: “Definiens and Leica Microsystems share a commitment to developing powerful imaging solutions that help researchers understand biological pathways faster and more accurately. This partnership will provide Leica customers with access to Definiens’ advanced image analysis software, enabling high-content screening that directly aids drug discovery efforts around the world.”

Dr Stefan Traeger, Managing Director of the Life Science Division of Leica Microsystems, said: “Together with Definiens, we look forward to the opportunity to make highly developed and future-proof high content screening solutions widely available for academic research as well. The combination of high-sensitivity confocal technology, miniaturized sample handling and reproducible evaluation with optimized data management is a sine qua non among drug discovery strategies and the analysis of their physiological relevance.”

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.